114 related articles for article (PubMed ID: 38353359)
1. HNRNPC promotes estrogen receptor-positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A-dependent manner.
Xu W; Huang Z; Xiao Y; Li W; Xu M; Zhao Q; Yi P
Mol Carcinog; 2024 May; 63(5):859-873. PubMed ID: 38353359
[TBL] [Abstract][Full Text] [Related]
2. Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression.
Lv W; Tan Y; Xiong M; Zhao C; Wang Y; Wu M; Wu Y; Zhang Q
J Transl Med; 2021 Dec; 19(1):527. PubMed ID: 34952600
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.
Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y
Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973
[TBL] [Abstract][Full Text] [Related]
4. HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells.
Gu Z; Yang Y; Ma Q; Wang H; Zhao S; Qi Y; Li Y
Respir Res; 2022 Dec; 23(1):362. PubMed ID: 36536402
[TBL] [Abstract][Full Text] [Related]
5. N6-Methyladenosine reader HNRNPC-mediated downregulation of circITCH prevents miR-224-3p sequestering and contributes to tumorigenesis in nasopharyngeal carcinoma.
Zhou Q; Song W; Li X; Lin J; Zhu C; Cao L; Li W; Lin S
Environ Toxicol; 2024 May; 39(5):2893-2907. PubMed ID: 38299319
[TBL] [Abstract][Full Text] [Related]
6. Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.
Shi S; Wu T; Ma Z; Zhang X; Xu K; Tian Q; Gao L; Yin X; Xu S; Yang S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4639-4651. PubMed ID: 36175801
[TBL] [Abstract][Full Text] [Related]
7. The m6A reader HNRNPC predicts adverse prognosis and promotes the progression of colorectal cancer.
Yu YM; Hu Y
Technol Health Care; 2024; 32(3):1445-1453. PubMed ID: 37661903
[TBL] [Abstract][Full Text] [Related]
8. HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis.
Lian B; Yan S; Li J; Bai Z; Li J
Mol Med; 2023 Aug; 29(1):103. PubMed ID: 37528369
[TBL] [Abstract][Full Text] [Related]
9. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC.
Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
[TBL] [Abstract][Full Text] [Related]
11. N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway.
Cai Y; Chen T; Wang M; Deng L; Li C; Fu S; Xie K
Diabetes Res Clin Pract; 2023 Mar; 197():110261. PubMed ID: 36681355
[TBL] [Abstract][Full Text] [Related]
12. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
[TBL] [Abstract][Full Text] [Related]
13. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
[TBL] [Abstract][Full Text] [Related]
14. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
15. Expression Pattern and Clinical Value of Key m6A RNA Modification Regulators in Abdominal Aortic Aneurysm.
Li T; Wang T; Jing J; Sun L
J Inflamm Res; 2021; 14():4245-4258. PubMed ID: 34511965
[TBL] [Abstract][Full Text] [Related]
16. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme.
Wang LC; Chen SH; Shen XL; Li DC; Liu HY; Ji YL; Li M; Yu K; Yang H; Chen JJ; Qin CZ; Luo MM; Lin QX; Lv QL
Front Oncol; 2020; 10():536875. PubMed ID: 33134160
[TBL] [Abstract][Full Text] [Related]
17. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
18. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
19. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner.
Chen H; Yu Y; Yang M; Huang H; Ma S; Hu J; Xi Z; Guo H; Yao G; Yang L; Huang X; Zhang F; Tan G; Wu H; Zheng W; Li L
Cell Biosci; 2022 Feb; 12(1):19. PubMed ID: 35197112
[TBL] [Abstract][Full Text] [Related]
20. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
